ProShare Advisors
NXTM

ProShare Advisors’s NxStage Medical Inc. NXTM Stock Holding History

ProShare Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,933
Closed -$221K – 1785
2018
Q3 		$221K Sell
7,933
-730
-8% -$20.5K ﹤0.01% 1544
2018
Q2 		$242K Buy
8,663
+361
+4% +$9.68K ﹤0.01% 1507
2018
Q1 		$206K Sell
8,302
-1,339
-14% -$32.6K ﹤0.01% 1530
2017
Q4 		$234K Buy
+9,641
New +$254K ﹤0.01% 1552
2017
Q1 		– Sell
-10,225
Closed -$268K – 1703
2016
Q4 		$268K Buy
+10,225
New +$253K ﹤0.01% 1445
2016
Q1 		– Sell
-9,205
Closed -$202K – 1682
2015
Q4 		$202K Buy
+9,205
New +$172K ﹤0.01% 1537
2015
Q2 		– Sell
-11,867
Closed -$205K – 1844
2015
Q1 		$205K Sell
11,867
-1,322
-10% -$23.4K ﹤0.01% 1714
2014
Q4 		$236K Sell
13,189
-11,213
-46% -$181K ﹤0.01% 1667
2014
Q3 		$320K Sell
24,402
-5,527
-18% -$74.4K ﹤0.01% 1677
2014
Q2 		$430K Sell
29,929
-30,562
-51% -$399K 0.01% 1681
2014
Q1 		$771K Buy
+60,491
New +$789K 0.01% 1510
2013
Q4 		– Sell
-37,737
Closed -$497K – 2123
2013
Q3 		$497K Buy
37,737
+4,040
+12% +$53K 0.01% 1472
2013
Q2 		$481K Buy
+33,697
New +$424K 0.01% 1355

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ProShare Advisors's NXTM Position: Q4 2018 in Review

ProShare Advisors sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 7,933 shares — an estimated $221K sold.

ProShare Advisors first reported a position in NXTM in Q2 2013 and held it in 13 quarters. The position peaked at $771K in Q1 2014. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • ProShare Advisors reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • ProShare Advisors sold 7,933 NxStage Medical Inc. shares in Q4 2018, an estimated $221K.
  • ProShare Advisors first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 13 quarters.
  • ProShare Advisors's NxStage Medical Inc. position peaked at $771K in Q1 2014.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on ProShare Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.